The Global cardiac monitoring and cardiac rhythm management devices market report focuses on current and future market growth, technological advancements, volume, raw materials, and profiles of the key companies involved in the market. The report provides valuable insights to the stakeholders, investors, product managers, marketing executives, and other industry professionals.
The Cardiovascular Disease Risk Score tool is built on Microsoft Azure Platform and a survey is done. Upon completion, algorithms will come out with a score specific to individual. This tool delivers a risk score that takes into account all contributing factors including lifestyle attributes such as diet, tobacco smoking preferences, and physical activity, which is developed using a combination of applied AI and clinical expertise on a large sample of retrospective data on health checks and coronary events.
Get Free Sample PDF Brochure @ https://www.emergenresearch.com/request-sample/364
Key questions answered in the report
- What will be the market size in terms of value and volume in the next five years?
- Which segment is currently leading the market?
- In which region will the market find its highest growth?
- Which players will take the lead in the market?
- What are the key drivers and restraints of the market’s growth?
Some major companies in the global market report include: Stryker, Medtronic, Abbott, Boston Scientific Corporation, Koninklijke Philips N.V., General Electric Company, Schiller Americas, Inc., MicroPort Scientific Corporation, Biotronik, and Nihon Kohden Corporation.
It focuses on the recent mergers & acquisitions, joint ventures, collaborations, partnerships, licensing agreements, brand promotions, and product launches, among others. The report also provides details about the company overview, business expansion plans, product portfolio, manufacturing and production capacity, global market position, financial status, and consumer base.
Some Key Highlights From the Report
- The cardiac rhythm management segment accounted for a significant revenue share in 2021. Significant advancements in medical devices and increasing number of market companies are major factors driving revenue growth of this segment. For instance, on 23 June 2022, Koninklijke Philips N.V. declared that the U.S. Center for Devices and Radiological Health (CDRH) of FDA have received Premarket Approval clearance (PMA) of HeartStart FR3 and HeartStart FRx Automated External Defibrillators (AEDs) from the company, as well as their ancillary parts including batteries and pads. HeartStart FR3 is a professional-grade AED with cutting-edge capabilities to aid medical professionals and first responders in treating cardiac arrest.
- The North America market accounted for largest revenue share in 2021 owing to well-established infrastructure coupled with increasing incidence of cardiovascular diseases such as ischemic heart disease, arrhythmia, and others in countries such as the U.S. and others. In addition, adoption of advanced technological devices is driving market revenue growth. For instance, on 16 March 2022, GE Healthcare and AliveCor announced a partnership to deliver medical-grade six-lead Electrocardiograms (ECGs), obtained by patients using an AliveCor KardiaMobile 6L ECG device outside of a hospital setting—at home or on the go—will be delivered directly into GE Healthcare's MUSE Cardiac Management System for doctors to monitor and assess the patients. This integration gives doctors access to trusted patient data within their current workflow, helping to increase diagnostic confidence and improving the ability to effectively manage patients proactively across care continuum.
To know more about the report @ https://www.emergenresearch.com/industry-report/cardiac-monitoring-and-cardiac-rhythm-management-devices-market
Cardiac Monitoring and Cardiac Rhythm Management Devices Market segmentation:
Emergen Research has segmented the global cardiac monitoring and cardiac rhythm management devices market based on product, end-use, and region:
- Product Outlook (Revenue, USD Billion; 2019-2030)
- Cardiac Monitoring
- Cardiac Rhythm Management
- End-Use Outlook (Revenue, USD Billion; 2019-2030)
- Hospitals
- Ambulatory Centres
- Home Healthcare
- Others
Regional Outlook: (Revenue, USD Billion; 2018-2028)
- North America (U.S.) (Canada) (Mexico)
- Europe (Germany) (UK) (France) (BENELUX) (Rest of Europe)
- Asia Pacific (China) (Japan) (South Korea) (Rest of APAC)
- Latin America (Brazil) (Rest of LATAM)
Click here to Get customization @ https://www.emergenresearch.com/request-for-customization/364
Table of Contents:
Chapter 1 includes an introduction of the global Cardiac Monitoring and Cardiac Rhythm Management Devices Market, along with a comprehensive market overview, market scope, product offerings, and an investigation of the market drivers, growth opportunities, risks, restraints, and other vital factors.
Chapter 2 offers an in-depth analysis of the key manufacturers engaged in this business vertical, along with their sales and revenue estimations.
Chapter 3 elaborates on the highly competitive terrain of the market, highlighting the key manufacturers and vendors.
In Chapter 4, our team has fragmented the Cardiac Monitoring and Cardiac Rhythm Management Devices market on the basis of regions, underscoring the sales, revenue, and market share of each region over the forecast timeline.
Chapters 5 and 6 have laid emphasis on the Cardiac Monitoring and Cardiac Rhythm Management Devices market segmentation based on product type and application
About Us:
At Emergen Research, we believe in advancing with technology. We are growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Thank you for reading our report. Please get in touch with us if you have any query regarding the report or its customization. Our team will ensure the report is best suited to your needs.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Read Full Press Release @ https://www.emergenresearch.com/press-release/global-cardiac-monitoring-and-cardiac-rhythm-management-devices-market
